Physician profile
George Jabbour
NPI 1861447856
$173,487.31
in general payments reported to CMS, 2019-2025
23 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,271 · 2020: $5,367 · 2021: $8,530 · 2022: $14K · 2023: $27K · 2024: $59K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $138K · Food and Beverage: $5,943 · Travel and Lodging: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $137,875.00 |
| Food and Beverage | $5,942.71 |
| Travel and Lodging | $341.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $168,566.95 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,570.47 | 2019-2025 | Lifevest |
| Medtronic, INC. | $995.14 | 2021-2025 | Corevalve Evolut R |
| Inari Medical, INC. | $467.19 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Recor Medical INC | $333.70 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Janssen Pharmaceuticals, INC | $261.23 | 2019-2022 | |
| Abbott Laboratories | $201.75 | 2019-2024 | Amplatzer Amulet, Mitraclip, Amplatzer Talisman |
| Abiomed | $170.68 | 2019-2025 | |
| Amgen INC. | $129.76 | 2022-2024 | Repatha |
| Shockwave Medical, INC | $116.72 | 2020 | |
| Philips North America LLC | $101.27 | 2024 | (P77) Azurion 7 M20 |
| Penumbra, INC. | $98.91 | 2020 | |
| Impulse Dynamics (USA) INC. | $92.22 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals Lp | $71.96 | 2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $70.92 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $61.55 | 2020 | |
| Novartis Pharmaceuticals Corporation | $60.19 | 2024 | |
| Medtronic Vascular, INC. | $29.90 | 2019 | |
| Dexcom, INC. | $29.33 | 2024 | Dexcom G6 Transmitter |
| Irhythm Technologies, INC. | $25.91 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiva Medical, INC. | $16.82 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Acist Medical Systems, INC. | $14.74 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Jabbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.